Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Personalized Medicine Market?

The market size for personalized medicine has seen significant expansion in the past few years. The growth is projected from $386.27 billion in 2024 to $426.82 billion in 2025, representing a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historical period include the emergence of companion diagnostics, the prevalence of patient-focused healthcare, a paradigm shift in drug development, the containment of healthcare costs, and an increase in chronic diseases.

What Growth Rate Is Forecasted for the Personalized Medicine Market by 2029?

The market size of personalized medicine is anticipated to see a significant increase in the coming years, reaching a projected $662.67 billion by 2029 with a compound annual growth rate (CAGR) of 11.6%. The growth during this forecasted period can be associated with the ongoing advancements in genomics, the expansion of biomarker discovery, the increasing adoption of telemedicine, supportive regulatory frameworks, and collaboration and data sharing. Major trends during the forecast period are expected to include the incorporation of artificial intelligence (AI), advances in genomic sequencing, integration of data and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision making, and collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Which Key Companies Are Shaping the Future of the Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Which Factors Are Driving Demand in the Personalized Medicine Industry?

The escalating incidence of unusual illnesses is projected to spur the expansion of the personalized medicine market. This growth is attributed to the increasing number of people diagnosed with disorders such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Individualized medicine provides custom-designed treatment strategies, catering to the specific healthcare needs of those suffering from rare diseases. For example, as confirmed by the Genetic Alliance UK, a national charity in the UK providing support to those affected by genetic, rare and undiagnosed diseases, there are approximately 3.5 million individuals in the UK living with a rare disorder, and 1 in every 17 individuals will experience a rare disease at some point in their life. Consequently, as the incidence of unusual diseases continues to surge, it is stimulating the growth of the personalized medicine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

How Is the Personalized Medicine Market Segmented by Several Divisions?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What are the Emerging Market Trends Driving the Growth of the Personalized Medicine Industry?

The trend of technological innovation is increasingly becoming prevalent in the personalized medicine industry. Top-tier companies in this market are harnessing new technologies in order to maintain their competitiveness. For example, in April 2023, OM1, an American healthcare firm which utilizes AI and real-world data to support healthcare providers, obtained a patent for an AI-powered platform aimed at advancing personalized medicine. This technology uses large-scale data analysis to deliver critical insights about diagnosis, disease progression, and treatment responses. Its value lies in providing customized healthcare recommendations, facilitating more informed decision-making for healthcare providers and speeding up clinical trials by effectively identifying appropriate candidates. This contributes to the progress of personalized medicine in the market.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Regions Are Driving Growth in the Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

This Report Delivers Insight On:

1. How big is the personalized medicine market, and how is it changing globally?

2. Who are the major companies in the personalized medicine market, and how are they performing?

3. What are the key opportunities and risks in the personalized medicine market right now?

4. Which products or customer segments are growing the most in the personalized medicine market?

5. What factors are helping or slowing down the growth of the personalized medicine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model